Outlook Therapeutics Inc. (NASDAQ: OTLK)
$9.23
+0.7800 ( +9.23% ) 262.8K
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
Market Data
Open
$9.23
Previous close
$8.45
Volume
262.8K
Market cap
$215.80M
Day range
$8.46 - $9.24
52 week range
$4.00 - $37.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Jul 08, 2024 |
| def | Proxies and info statements | 6 | Jun 26, 2024 |
| pre | Proxies and info statements | 6 | Jun 14, 2024 |
| 8-k | 8K-related | 13 | May 28, 2024 |
| 10-q | Quarterly Reports | 69 | May 15, 2024 |
| 8-k | 8K-related | 15 | May 15, 2024 |
| 8-k | 8K-related | 15 | May 13, 2024 |
| 8-k | 8K-related | 14 | May 01, 2024 |
| 4 | Insider transactions | 1 | Apr 17, 2024 |
| 8-k | 8K-related | 13 | Apr 15, 2024 |